Inactive Instrument

Other languages Sierra Oncology, Inc.

Equities

SRRA

US82640U4040

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Sierra Oncology, Inc. Announces Update on Sra737	06/23/06
Sierra Oncology, Inc. Announces Executive Changes	02/22/02
GSK Completes $1.9 Billion Purchase of Sierra Oncology	01/22/01
GlaxoSmithKline plc completed the acquisition of Sierra Oncology, Inc. from Frazier Healthcare VI, L.P., Frazier Life Sciences VIII, L.P., Frazier Life Sciences Public Fund, L.P., all managed by Frazier Management, L.L.C., and others.	01/22/01
Sierra Oncology Shareholders Approve Acquisition by GSK	30/22/30
Sierra Oncology, Inc. Announces Submission of New Drug Application for Momelotinib to US Food & Drug Administration	17/22/17
Pfizer sortira des soins grand public de GSK après la scission	01/22/01
Pfizer to sell stake in GSK's consumer health business after it lists	01/22/01
GSK plc : GSK compra Affinivax por 3.300 millones de dólares	31/22/31
GSK achète Affinivax pour 3,3 Mds$	31/22/31
GSK to spend up to $3.3 bln on Affinivax to boost vaccines roster	31/22/31
Sierra Oncology, Inc. Announces Momelotinib Pivotal Phase 3 Data Receives Oral Presentation At American Society of Clinical Oncology Annual Meeting	27/22/27
Sierra Oncology's Q1 Net Loss Narrows	06/22/06
Sierra Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	06/22/06
GSK porté par le rebond de ses ventes en début d'année	27/22/27
GSK: bénéfice net en hausse de 68% au 1er trimestre	27/22/27
GSK tops forecasts as consumer health spin-off nears	27/22/27
MÄRKTE USA/Quartalszahlen und Wetten auf geringere Inflation stützen	14/22/14
Wall Street hoger gesloten	14/22/14
Sector Update: Health Care Stocks Putting Up Modest Gains This Afternoon	14/22/14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Sierra Oncology, Inc.

Equities

SRRA

US82640U4040

Other languages

Filters